Flex Pharma Inc.

(FLKS) Trade

By |

Profile

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. The company operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.

Contact Information

Website: www.flex-pharma.com
Email: irdept@flex-pharma.com
Main Phone: +1 617 874-1821
Address: 800 Boylston Street
Address 2: 24th Floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02199

Issuer Information

Exchange: NSD
CEO: William K. McVicar
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.41 $ -0.011331 (-2.70%)
Last Price 0.41 Change $ -0.011331 Change % -2.70 Tick N/A
Bid N/A Bid Size 0.00 Ask 0.71 Ask Size 100.00
Open 0.42 High 0.43 Low 0.40 Prev Close 0.42
Last Trade Volume 255,084 52 Wk Hi 8.98 52 Wk Low 0.38
Market Cap 7.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 18,069,476.00 EPS (TTM) -1.56 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Christoph H. Westphal 1,000
John McCabe 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Christoph H. Westphal 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 40 40 40 40
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 17 17 17 17
Standard Deviation 14 14 14 14
Date of Most Recent Estimate 05/29/18 05/29/18 05/22/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.4